Human endothelial cells or human foreskin fibroblasts infected with herpes simplex viruses (HSVs) potently inhibit the lytic activity of natural killer cells and interleukin 2-activated killer cells. The inhibition occurs after as little as 8 hr of viral infection and requires contact between effector cells and HSV-infected targets. Inhibition evidently stems from direct blockade of killer cell function because killer cells placed atop HSV-infected targets rapidly become incapable of lysing subsequently added HL-60 or K-562 cells. The impairment of killer cell function is prevented when protein glycosylation in HSV-infected cells is blocked with tunicamycin. These studies may be relevant for understanding the persistence of herpes simplex virus infections and, further, suggest a mechanism for failed immune surveillance. A particularly relevant instance in which the immune system fails to eliminate a viral pathogen is that of human infection with herpes simplex virus (HSV). NK cells are necessary to control HSV in humans (10) but, nevertheless, fail to eradicate the infection. While investigating the role of killer lymphocytes in the recognition and elimination of HSV-infected cells, we made the unexpected observation that cytolytic activity of NK cells and LAK cells is remarkably suppressed following their contact with HSV-infected target cells. This down-regulation of cytotoxic effectors by cells infected with a common virus not only suggests a mechanism for persistence of HSV infections but also may serve as a model, in general, of failed immune surveillance.
Natural killer cells (NK cells) are thought to eliminate abnormal cells that arise from parasitism by intracellular pathogens, particularly viruses, or from oncogenic stimuli causing malignant transformation (1) (2) (3) . NK cells are normally present in the circulation and, along with other populations of lymphocytes, are further activated by the T-cell lymphokine interleukin 2 (IL-2) (4) (5) (6) (7) (8) (9) . These so-called lymphokine-activated killer cells, or LAK cells, display a greater lytic capacity and recognize a broader range of target cells than their nonactivated counterparts (6) (7) (8) (9) . Despite these presumably capable killer cells, humans are frequently afflicted with cancer and with persistent or recurrent viral infections.
A particularly relevant instance in which the immune system fails to eliminate a viral pathogen is that of human infection with herpes simplex virus (HSV). NK cells are necessary to control HSV in humans (10) but, nevertheless, fail to eradicate the infection. While investigating the role of killer lymphocytes in the recognition and elimination of HSV-infected cells, we made the unexpected observation that cytolytic activity of NK cells and LAK cells is remarkably suppressed following their contact with HSV-infected target cells. This down-regulation of cytotoxic effectors by cells infected with a common virus not only suggests a mechanism for persistence of HSV infections but also may serve as a model, in general, of failed immune surveillance.
METHODS
Cell Culture. Human foreskin fibroblasts were cultured in tissue culture medium (RPMI-1640 with 25 mM Hepes supplemented with 2 mM L-glutamine, 100 units of penicillin per ml, and 100 ,ug of streptomycin per ml) and 10% (vol/vol) fetal bovine serum. Human umbilical vein endothelium was prepared and cultured as described (11) . K-562 and HL-60 cell lines were grown in suspension culture in the same medium as above. They were passaged as necessary to maintain the density below 106 cells per ml.
Virus Infection. HSV type 1 (HSV-1), strain 17 syn+, and HSV type 2 (HSV-2), strain HG52, were propagated and titrated in rabbit skin cells as described (12) . Virus stock was prepared at 107 plaque-forming units (pfu)/ml of tissue culture medium with 5% calf serum and stored at -700C in small aliquots. Confluent monolayers of target cells were infected with HSV by overlaying with 100 ,ul of virus stock per well and incubating for 1 hr at 350C (multiplicity of infection 10 pfu per target cell). After the infecting incubation, the spent virus stock was removed and monolayers were overlaid with their original medium and incubated for various times before exposing them to killer cells.
In experiments comparing the effects of adenovirus, strain AD4, to those of HSV, A549 cells were used as targets (13, 14) . Viral infection of A549 cells was carried out as above.
Killer Cells. NK activity was assayed in freshly isolated peripheral blood mononuclear cells. From 60 ml of sterile, heparinized venous blood, 3-ml samples were mixed with 5 ml of sterile phosphate-buffered saline and overlaid onto 3 ml of Histopaque-1077 (Sigma). The tubes were centrifuged at 400 x g for 30 min at room temperature; then the mononuclear cell layers were recovered and pooled. The resulting cell fraction was washed twice in phosphate-buffered saline and suspended in tissue culture medium. LAK cells were generated from peripheral blood mononuclear cells prepared from 42 ml of venous blood as above, but after the final wash the cells were suspended in tissue culture medium supplemented with 5% human serum and 1000 units of recombinant IL-2 per ml (Cetus). The cell concentration was adjusted to 106 per ml and the cells were incubated in a tissue culture incubator for 6 or 7 days.
An NK cell-enriched population of LAK cells was prepared by modification of the technique reported by Melder et al. (15) . Briefly, peripheral blood mononuclear cells were isolated from 42 ml of venous blood and suspended at 107 per ml in tissue culture medium. Monocytes were depleted by adherence to plastic for 90 min at 37°C. The monocytedepleted mononuclear cells were then suspended at 2 x 106 per ml in the above LAK cell medium and placed in 25-cm2 culture flasks in a tissue culture incubator for 24 hr, after which the nonadherent cell fraction was suspended by rocking, removed, and set aside. The adherent cell layer was washed twice; the washes were discarded. The nonadherent cell fraction was then centrifuged and one-halfof the resulting supernatant fluid was combined with an equal volume of fresh LAK cell medium. This conditioned medium was (17) .
In some experiments, cytotoxicity was measured in sandwiches consisting of a monolayer of unlabeled, adherent target cells either infected or not with HSV. This adherent layer was then overlaid with effector cells and, subsequently, with a labeled target cell layer, either HL-60 cells or K-562 cells.
The adherence of effector cells to target cell monolayers was determined as described (16) . In brief, effector cells were washed and then labeled for 2 hr at 370C with 80-100 ;kCi of 51Cr. The labeled cells were washed twice and suspended at the desired concentration. Confluent monolayers of fibroblasts or endothelial cells, pretreated as described for the particular experiment, were washed and overlaid with radiolabeled effector cells. Contact was ensured by centrifugation as above and the plate was incubated for 1 hr. The nonadherent cells were removed from each well by aspiration; the adherent cell layer was washed twice. Total radioactivity in the pooled nonadherent fractions and in the adherent fraction was determined as above, and the % nonadherence (representing nonadherent cells and spontaneously released radioactivity) was calculated for each well; replicates were then averaged. The % spontaneous release of 51Cr from labeled effectors occurring over the course of the experiment was determined independently. Percent specific adherence was calculated as: 100 -(mean % nonadherence -mean % spontaneous release/100% -mean % spontaneous release).
Statistical Testing. Individual datum points were compared by Student's two-tailed t test applied to the mean and SD of replicate samples.
RESULTS
Human foreskin fibroblasts infected for 4 hr with HSV-1 are, as previously shown (1, 2), more readily lysed by NK cells than are noninfected controls (Fig. LA) . Surprisingly, however, as the viral infection progresses, this enhanced sensitivity to NK cell lysis is lost (Fig. lA ). This reversal is not an artifact of the more prolonged virus infection-that is, (i) target cells retain full viability for >48 hr following HSV-1 infection, (ii) 51Cr, which is used in the cytotoxicity assay, is identically incorporated by virus-infected targets and normal control cells, and (iii) the spontaneous release of this radiolabel in the absence of NK cells is the same for infected and uninfected cells.
The defective killing of HSV-infected targets also obtains for LAK cells, which ordinarily are more efficient and recognize a broader range of target cells. In fact, LAK cells readily lyse cultured, uninfected human fibroblasts (Fig. 1B) ; however, LAK cell lysis offibroblasts infected for 18 hr with HSV-1 is markedly curtailed (Fig. 1B, left) . Furthermore, diminished destruction by LAK cells is not unique to HSV-1-infected fibroblasts but also occurs with infected human endothelial cells (Fig. 1B, right) . Endothelial In the second instance, target cells were exposed to HSV-1 that had been inactivated by UV irradiation (pfu/ml following irradiation = 0) (21). Although such UV-inactivated viruses attach to target cells, their replication is deficient; concomitantly they were unable to provoke inhibition of LAKmediated lysis.
The killing of target cells by NK and LAK cytotoxic effectors proceeds through a series of coordinated steps In analogous sandwich experiments, the ability ofNK cells to lyse K-562 targets was similarly inhibited by contact with 18-hr HSV-1-infected fibroblasts. As expected, however, NK cells that contact uninfected fibroblasts, or those that contact fibroblasts infected with HSV-1 for only 4 hr, readily lyse K-562 cells. For example, in two experiments at an E: T ratio of 32, lysis of K-562 by NK cells exposed to uninfected fibroblasts was 54% 3.4% and 64% 1.8%. For NK cells on 4-hr HSV-1-infected fibroblasts, lysis of K-562 was identical (55% 2.8% and 65% 1.8%, respectively). In contrast, NK cells on 18-hr HSV-1-infected fibroblasts lysed only 33% 3.4% and 46% 1.3%, respectively. In each experiment, the values for 18-hr infection were significantly lower than uninfected or 4-hr infection (P < 0.001).
In further experiments with the sandwich model, we selectively radiolabeled either the infected, bottom (fibroblasts) layer or the uninfected, top (HL-60) layer and examined lysis by LAK effectors. These experiments (data not shown) confirmed that with 18-hr HSV-1 infection the decrease in target cell lysis was global-i.e., neither underlying nor overlying target cells were efficiently lysed by LAK cells exposed to HSV-1-infected fibroblasts. (22) . However, blockade of prostaglandin production with indomethacin has no direct effect on LAK cell killing of normal targets nor does it restore LAK cell cytolysis of HSV-1-infected targets (Table  3 , experiment 3). Finally, virus-infected cells apparently inhibit cytolytic activity ofkiller cells without assistance from accessory cells. We prepared a homogeneous population of LAK cells (15) , >90% demonstrating a NK phenotype-CD-3 negative and CD-16 positive. These purified killer cells also failed to lyse HSV-1-infected targets (Fig. 1D) .
Thus, the inhibition of killer cell activity is mediated by their direct contact with HSV-infected cells; we sought to determine whether a surface-expressed molecule on infected cells is responsible. Tunicamycin, an inhibitor of N-linked protein glycosylation, blocks the de novo synthesis of host cell and viral glycoproteins (23) . We find that target cells infected with HSV-1 and then incubated for 18 hr in the presence of tunicamycin lose the capacity to inhibit LAK cell cytolysis (Table 4 ). This suggests that surface expression of glycoproteins is critically involved in suppressing killer cell lytic efficiency. As further confirmation, tunicamycin also fully restored lytic activity against HL-60 cells in sandwiches of LAK cells plus HSV-1-infected fibroblasts (not shown). Although viral proteins homologous, and potentially inhibitory, to IL-2 have been recently described (24, 25) , the suppressive glycoproteins on HSV-infected cells are apparently unrelated-that is, direct addition of recombinant IL-2 (1000 units/ml) to the cytolysis assay modestly enhances LAK-cell-specific lysis of HSV-1-infected cells (from 1.6% + 4.2% to 9.8% ± 4%, P < 0.03 by Student's two-tailed t test-but this increment is minimal, and lysis compared to MThe usual cytolytic assays were conducted in the presence of indomethacin.
The observation that HSV-1-infected target cells can inhibit NK and LAK cell function might appear to conflict with previously published information (1, 2). Indeed, the ability of peripheral blood mononuclear cells to lyse HSV-1-infected fibroblasts has been a traditional measure of NK cell activity. Our results, however, do not contradict these earlier studies. We find that fibroblasts and endothelial cells briefly infected with HSV-1 are, in fact, lysed by peripheral blood mononuclear cells, whereas uninfected controls are not. It is only later in the course of HSV-1 infection (18 hr) that the inhibitory activity is seen (Fig. IA) (26, 27) . To review: these workers demonstrated that NK cells following contact with naturally occurring, NKresistant targets would no longer efficiently lyse K-562 cells.
This inhibition did not involve accessory mononuclear cells and was independent of soluble factors. Onset of cytolysis inhibition was very slow, minimally detectable after 3 hr of contact between NK cells and NK-resistant targets and <50o decreased after 20 hr of contact. Those results are qualitatively similar to our own studies; however, we find that HSV-1-infected targets inhibit NK cell cytotoxicity more rapidly and to a greater degree.
Perhaps more relevant to the present studies are recent reports that NK cell function is inhibited by peptides corresponding to portions of transmembrane retroviral glycoproteins (28, 29) . For instance, a 17-amino acid peptide, corresponding to a highly conserved region in the envelope proteins of murine leukemia virus and feline leukemia virus and in the transmembrane glycoproteins of human T-cell lymphotrophic viruses I and II, was shown to inhibit NK cell lysis of K-562 cells (28) . In a more recent study, two peptides, corresponding to regions of the gp4l transmembrane glycoprotein of human immunodeficiency virus, were also shown to inhibit NK cell cytolytic activity (29) . When NK cells incubated with the inhibitory peptides were then treated for several hours with recombinant IL-2, lytic activity increased somewhat but was still deficient compared to control effectors.
The seeming paradox has not escaped our attention that HSV-1-infected targets, which are ultimately doomed to destruction by their infection, develop the capacity to inhibit NK and LAK cell cytolytic function. Finally, taken together, our results and those of others may imply existence of a signal transduction pathway in NK cells and IL-2-activated killer cells whose activation inhibits lytic activity. Confirmation that such an inhibitory pathway exists would provide insights into killer cell regulation and, perhaps, suggest a mechanism for failure of immune surveillance.
